title: Successful conservative treatment of endometrial carcinoma permitting subsequent pregnancy: report of two cases.
abstract: Two women with endometrial carcinoma who wished to preserve their childbearing ability received conservative treatment by medroxyprogesterone acetate (MPA, 600 mg/day for 22 weeks and 29 weeks, respectively). Following regression of endometrial lesions, their infertility was treated by inducing ovulation. Intact pregnancy was diagnosed 13 months and 11 months after completion of the MPA treatment, respectively. One patient had a twin pregnancy and delivered two infants at 35 weeks of gestational age. The other patient delivered a full-term baby. They had no evidence of recurrence 60 months and 31 months after the conservative treatment, respectively. We believe this conservative treatment with progestin may be safely performed for young patients with endometrial cancer who wish to preserve their fertility.
authors.affiliation: Department of Obstetrics and Gynecology, School of Medicine, Kitasato University, Kanagawa, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Jobo
authors.forename: M
authors.initials: M
authors.lastname: Imai
authors.forename: M
authors.initials: M
authors.lastname: Kawaguchi
authors.forename: M
authors.initials: M
authors.lastname: Kenmochi
authors.forename: H
authors.initials: H
authors.lastname: Kuramoto
mesh_terms: D000230:Adenocarcinoma / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology*; D000328:Adult; D004334:Drug Administration Schedule; D016889:Endometrial Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008525:Medroxyprogesterone / Q000008:administration & dosage*; D011247:Pregnancy; D045167:Progesterone Congeners / Q000008:administration & dosage*; D016896:Treatment Outcome
chemical_list: D045167:Progesterone Congeners; D008525:Medroxyprogesterone